(Q30577239)

25 June 2017

1 reference

title

The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data (English)

1 reference

25 June 2017

Carbon C

1

1 reference

25 June 2017

Poole MD

series ordinal

2

1 reference

25 June 2017

publication date

1 April 1999

1 reference

25 June 2017

published in

Journal of Chemotherapy

1 reference

25 June 2017

volume

11

1 reference

25 June 2017

issue

2

1 reference

25 June 2017

page(s)

107-118

1 reference

Resistance to Erythromycin in Group A Streptococci

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Comparative activities of amoxycillin and 10 other oral drugs against penicillin-susceptible and -resistant Streptococcus pneumoniae strains recently isolated in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Erythromycin: a microbial and clinical perspective after 30 years of clinical use (1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Autobacteriographic studies of clarithromycin and erythromycin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Gynaecological tissue levels of azithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

The site concentrations of antimicrobial agents in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Azithromycin (CP-62,993) in acute exacerbations of chronic bronchitis: an open clinical, microbiological and pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Erythromycin: a review of its uses in pediatric practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter, open comparative study. The Swiss Tonsillopharyngitis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

Prescription of Macrolides in Community-Acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.1999.11.2.107

10.1179/JOC.1999.11.2.107

21 January 2018

Identifiers

DOI

1 reference

25 June 2017

1 reference